Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.42 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | CASP7 | P55210 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | NSD2 | O96028 | 2/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL138254 | 0.87 | CA2 (0.55) | CD44CA2CYP3A4TSHRPIK3CA | |
| SCHEMBL8512559 | 0.85 | CD44 (0.48) | CD44CA2CYP3A4TSHRPIK3CA | |
| SCHEMBL2020228 | 0.79 | CD44 (0.43) | CD44CA2CYP3A4TSHRPIK3CA | |
| SCHEMBL70170 | 0.79 | TSHR (0.50) | CA2CYP3A4TSHRPIK3CAGABRA1 | |
| SCHEMBL30154643 | 0.78 | GABRA1 (0.56) | CD44CA2CYP3A4TSHRPIK3CA | |
| SCHEMBL1804107 | 0.78 | GABRA1 (0.56) | CD44CA2CYP3A4TSHRPIK3CA | |
| SCHEMBL2056782 | 0.78 | CA2 (0.46) | CD44CA2CYP3A4TSHRPIK3CA | |
| SCHEMBL5163816 | 0.78 | CYP3A4 (0.59) | CD44CA2CYP3A4TSHRPIK3CA | |
| SCHEMBL29919506 | 0.78 | CD44 (0.41) | CD44CA2CYP3A4TSHRPIK3CA | |
| SCHEMBL28888577 | 0.77 | CD44 (0.44) | CD44CYP3A4TSHRPIK3CAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116063238-A | Java oxine compound and preparation method thereof | 上海交通大学 | 2023-05-05 | — | — | CN | claimed |
| CN-115974796-A | Woxine medicinal molecule and preparation method thereof | 上海交通大学 | 2023-04-18 | — | — | CN | claimed |
| US-4992527-A | Heat resistance, protective coatings, electronics | AMOCO CORPORATION (US) | 1991-02-12 | — | — | US | claimed |
| US-4973659-A | HEAR RESISTANT FILMS, FIBERS, COMPOSITES | AMOCO CORPORATION (US) | 1990-11-27 | — | — | US | claimed |
| US-4968780-A | SOLUBLE IN N-METHYLPYRROLIDONE, HIGH GLASS TRANSITION TEMPERATURE, HEAT RESISTANT FILMS, FIBERS AND COMPOSITES | AMOCO CORPORATION (US) | 1990-11-06 | — | — | US | claimed |
| EP-0219709-B1 | POLYMETHYLENE POLYPHENYLAMINE MODIFIED DIAMINE CHAIN EXTENDERS AND POLYUREA ELASTOMERS THEREFROM | THE DOW CHEMICAL COMPANY (US) | 1989-11-23 | — | — | EP | claimed |
| EP-0219709-A2 | Polymethylene polyphenylamine modified diamine chain extenders and polyurea elastomers therefrom | THE DOW CHEMICAL COMPANY (US) | 1987-04-29 | — | — | EP | claimed |
| EP-0153606-A2 | Process for the production of polyurethane urea elastomers | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1985-09-04 | — | — | EP | claimed |
| US-4482690-A | AROMATIC DIAMINE AS CHAIN EXTENDER | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1984-11-13 | — | — | US | claimed |
| CN-118359811-A | Soluble polyimide and method for preparing epoxy resin composite material by using same | 安徽大学 | 2024-07-19 | — | — | CN | disclosed |
| US-11932635-B2 | CRBN ligands and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| CN-116063238-A | Java oxine compound and preparation method thereof | 上海交通大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-115974796-A | Woxine medicinal molecule and preparation method thereof | 上海交通大学 | 2023-04-18 | — | — | CN | disclosed |
| EP-0153606-A3 | PROCESS FOR THE PRODUCTION OF POLYURETHANE UREA ELASTOMERS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1987-02-04 | — | — | EP | disclosed |
| EP-0178583-A1 | Polyurethane systems using monotertiary-alkyltoluenediamine as a cross linker | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1986-04-23 | — | — | EP | disclosed |
| EP-0153606-A2 | Process for the production of polyurethane urea elastomers | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1985-09-04 | — | — | EP | disclosed |
| EP-0153606-A2 | Process for the production of polyurethane urea elastomers | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1985-09-04 | — | — | EP | disclosed |
| US-4482690-A | AROMATIC DIAMINE AS CHAIN EXTENDER | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1984-11-13 | — | — | US | disclosed |
| US-4482690-A | AROMATIC DIAMINE AS CHAIN EXTENDER | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1984-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | CRBN, CRKL, ERBB3 | CD44 1646/4885CA2 3842/4885CYP3A4 4566/4885 |
| US-11932635-B2 | CRBN ligands and uses thereof | CRBN, CRKL, ERBB3 | CD44 1646/4885CA2 3842/4885CYP3A4 4566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.